{"id":"W2553056958","doi":"10.1097/fjc.0000000000000445","title":"Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia–Pacific Region: A Phase 3 Randomized Controlled Trial","year":2016,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cardiome (Canada)","funders":"Cardiome Pharma Corp.","keywords":"Medicine; Cardioversion; Placebo; Atrial fibrillation; Sinus rhythm; Internal medicine; Cardiology; Anesthesia; Clinical endpoint; Randomized controlled trial; Adverse effect","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006441513,0.0001435725,0.0026421,0.0002919901,0.00003710649,0.000005409295,0.0000882531,0.0001045109,0.0000305863],"category_scores_gemma":[0.00160246,0.00007219111,0.00336491,0.0001737701,0.0001430544,0.00009578995,0.00002317154,0.00009708909,3.447542e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005898715,"about_ca_system_score_gemma":0.0001292776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002309383,"about_ca_topic_score_gemma":9.58003e-8,"domain_scores_codex":[0.9964035,0.001471846,0.001312769,0.0001387918,0.0005251852,0.000147967],"domain_scores_gemma":[0.9952986,0.003154516,0.0009757472,0.0001758942,0.000338059,0.00005716089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9725,0.00002299717,0.0003144315,0.00005240318,0.008966428,0.00003085108,0.000130274,0.0004589108,0.001161539,0.00004983108,0.0007777566,0.01553456],"study_design_scores_gemma":[0.929019,0.001062145,0.0002888409,0.00006933072,0.009249886,0.0001815297,0.00007765357,0.0001207928,0.0004891788,0.00005219034,0.05932145,0.00006794346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633433,0.01063469,0.007789733,0.006188279,0.002415027,0.009332856,0.00001161728,0.000007157868,0.0002773903],"genre_scores_gemma":[0.9812179,0.01613371,0.0001410875,0.00002041093,0.002420465,0.000005905012,0.000003873362,0.00001127858,0.00004534044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05854369,"threshold_uncertainty_score":0.3393601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04227251242056037,"score_gpt":0.3486379242290639,"score_spread":0.3063654118085035,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}